Abstract
BackgroundPatients with PNS are frequently excluded from clinical trials involving ICIs due to safety concerns. Herein, we study the safety and clinical outcomes of ICIs in patients with solid tumors...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
